DYSLIPIDEMIA: OVERVIEW OF THE ESC/EAS 2019 RECOMMENDATIONS FOR DIAGNOSTICS AND TREATMENT. PART 1 – RISK ASSESSMENT
Journal: Journal of the Grodno State Medical University (Vol.19, No. 1)Publication Date: 2021-03-30
Authors : V. M. Pyrochkin; Y. I Karpovich; E. V. Mironchik; A. V. Kovtun;
Page : 119-122
Keywords : cardiovascular disease; cardiovascular risk; dyslipidemia; pharmacotherapy;
Abstract
The high incidence of cardiovascular disease leads to a routine individual assessment of the patient's cardiovascular risk, and to the correction of therapy. In 2019, at the European Congress of Cardiology, updated recommendations of the ESC/EAS (European Society of Cardiology / European Atherosclerosis Society) on the diagnosis and treatment of dyslipidemia were presented, new approaches to cardiovascular risk assessing and correction of dyslipidemia were formulated. The article discusses the main aspects of clinical use of the new recommendations for the treatment of this pathology.
Other Latest Articles
- POSSIBILITIES OF DIAGNOSIS AND SURGICAL TREATMENT OF COMPLICATIONS OF VIRAL LUNG DAMAGE IN COVID-19
- COPING WITH AUTISM: DIFFERENTIAL & UNIQUE PARENTING MOTHERS JOURNEY TOWARDS ADAPTATION-A QUALITATIVE STUDY IN INDIAN CONTEXT BASED ON GROUNDED THEORY APPROACH
- REGULARITIES OF POSTNATAL DEVELOPMENT OF BRAIN NEURONS
- PHOTODYNAMIC THERAPY OF EXPERIMENTAL CHOLANGITIS
- TRICHINOSIS AS A FACTOR DETERMINING THE CHANGE IN THE EXPRESSION OF PROTOONCOGENES AND SUPPRESSOR GENE IN EXPERIMENT
Last modified: 2021-03-31 16:29:23